• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.

作者信息

Gautret Philippe, Hoang Van Thuan, Lagier Jean-Christophe, Raoult Didier

机构信息

IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.

IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.

出版信息

Int J Antimicrob Agents. 2021 Jan;57(1):106237. doi: 10.1016/j.ijantimicag.2020.106237.

DOI:10.1016/j.ijantimicag.2020.106237
PMID:33408027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7779261/
Abstract
摘要

相似文献

1
Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.羟氯喹对新型冠状病毒肺炎疗效评估的回应：一项开放标签非随机临床试验的二次分析
Int J Antimicrob Agents. 2021 Jan;57(1):106237. doi: 10.1016/j.ijantimicag.2020.106237.
2
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.羟氯喹预防 COVID-19 的集群随机试验。
N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24.
3
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.阿奇霉素联合羟氯喹治疗因 2019 冠状病毒病（COVID-19）入住重症监护病房的患者：随机对照试验 AZIQUINE-ICU 的方案。
Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.
4
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev .对莫伊谢耶夫所著《羟氯喹/氯喹在预防严重急性呼吸综合征冠状病毒2感染（2019冠状病毒病）方面是否有未来？》的回应
Ann Rheum Dis. 2021 Feb;80(2):e20. doi: 10.1136/annrheumdis-2020-217636. Epub 2020 Apr 28.
5
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.羟氯喹能保护风湿病患者免受新型冠状病毒肺炎（COVID-19）感染吗？对Heldwein和Calado所著的《羟氯喹能预防新型冠状病毒肺炎（COVID-19）传播吗？》以及Joob和Wiwanitkit所著的《系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新型冠状病毒肺炎（COVID-19）患者：一则评论》的回应
Ann Rheum Dis. 2020 Jun;79(6):e62. doi: 10.1136/annrheumdis-2020-217524. Epub 2020 Apr 23.
6
Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?羟氯喹啉/氯喹啉在预防新型冠状病毒感染（COVID-19）方面还有未来吗？
Ann Rheum Dis. 2021 Feb;80(2):e19. doi: 10.1136/annrheumdis-2020-217570. Epub 2020 Apr 21.
7
Hydroxychloroquine for COVID-19: Balancing contrasting claims.用于治疗新冠肺炎的羟氯喹：权衡相互矛盾的说法。
Eur J Intern Med. 2020 Dec;82:25-26. doi: 10.1016/j.ejim.2020.11.018. Epub 2020 Nov 23.
8
Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.关于《发现》试验中羟氯喹治疗新冠病毒感染起始负荷剂量的理论依据的评论。
J Antimicrob Chemother. 2021 Jan 1;76(1):276-277. doi: 10.1093/jac/dkaa327.
9
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.对帕尔佩里斯所著《在严重急性呼吸综合征冠状病毒2（新冠病毒病）大流行中是否将抗疟药用作预防性干预措施》的回应
Ann Rheum Dis. 2021 Jan;80(1):e9. doi: 10.1136/annrheumdis-2020-217634. Epub 2020 May 4.
10
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.在2019冠状病毒病（COVID-19）大流行中，是否将抗疟药作为一种预防性干预措施加以考虑。
Ann Rheum Dis. 2021 Jan;80(1):e8. doi: 10.1136/annrheumdis-2020-217557. Epub 2020 Apr 22.

引用本文的文献

1
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒清除的影响：对埃尔韦·塞利格曼的回应
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.

本文引用的文献

1
Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.羟氯喹治疗新型冠状病毒肺炎的疗效评估：一项开放标签非随机临床试验的二次分析
Int J Antimicrob Agents. 2021 Jan;57(1):106172. doi: 10.1016/j.ijantimicag.2020.106172.